Literature DB >> 28784606

Genetic-Genomic Insights Into the Metabolic Determinants of Spontaneous Atrial Fibrillation.

Shamone R Gore-Panter1, Julie H Rennison1, David R Van Wagoner2.   

Abstract

Entities:  

Keywords:  Editorials; atrial fibrillation; gene expression; pharmacology; transcription factors

Mesh：

Substances：

Year:  2017        PMID： 28784606      PMCID： PMC5673115          DOI： 10.1161/CIRCEP.117.005636

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN： 1941-3084


× No keyword cloud information.
  14 in total

Review 1.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

2.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

3.  Characterization of the Genetic Program Linked to the Development of Atrial Fibrillation in CREM-IbΔC-X Mice.

Authors:  Matthias D Seidl; Juliane Stein; Sabine Hamer; Florentina Pluteanu; Beatrix Scholz; Eva Wardelmann; Andreas Huge; Anika Witten; Monika Stoll; Elke Hammer; Uwe Völker; Frank U Müller
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-08

4.  Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence.

Authors:  Amrish Deshmukh; John Barnard; Han Sun; David Newton; Laurie Castel; Gosta Pettersson; Douglas Johnston; Eric Roselli; A Marc Gillinov; Kenneth McCurry; Christine Moravec; Jonathan D Smith; David R Van Wagoner; Mina K Chung
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-18

5.  Atrial L-type Ca2+ currents and human atrial fibrillation.

Authors:  D R Van Wagoner; A L Pond; M Lamorgese; S S Rossie; P M McCarthy; J M Nerbonne
Journal:  Circ Res       Date:  1999-09-03       Impact factor: 17.367

6.  Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice.

Authors:  Frank U Müller; Geertje Lewin; Hideo A Baba; Peter Bokník; Larissa Fabritz; Uwe Kirchhefer; Paulus Kirchhof; Karin Loser; Marek Matus; Joachim Neumann; Burkhard Riemann; Wilhelm Schmitz
Journal:  J Biol Chem       Date:  2004-11-29       Impact factor: 5.157

7.  Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

Authors:  David R Van Wagoner; Jonathan P Piccini; Christine M Albert; Mark E Anderson; Emelia J Benjamin; Bianca Brundel; Robert M Califf; Hugh Calkins; Peng-Sheng Chen; Nipavan Chiamvimonvat; Dawood Darbar; Lee L Eckhardt; Patrick T Ellinor; Derek V Exner; Richard I Fogel; Anne M Gillis; Jeff Healey; Stefan H Hohnloser; Hooman Kamel; David A Lathrop; Gregory Y H Lip; Reena Mehra; Sanjiv M Narayan; Jeffrey Olgin; Douglas Packer; Nicholas S Peters; Dan M Roden; Heather M Ross; Robert Sheldon; Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2014-11-18       Impact factor: 6.343

8.  Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice.

Authors:  Paulus Kirchhof; Eloi Marijon; Larissa Fabritz; Na Li; Wei Wang; Tiannan Wang; Kirsten Schulte; Juliane Hanstein; Jan S Schulte; Mathis Vogel; Nathalie Mougenot; Sandra Laakmann; Lisa Fortmueller; Jens Eckstein; Sander Verheule; Sven Kaese; Ariane Staab; Stephanie Grote-Wessels; Ulrich Schotten; Ghassan Moubarak; Xander H T Wehrens; Wilhelm Schmitz; Stéphane Hatem; Frank Ulrich Müller
Journal:  Int J Cardiol       Date:  2011-11-16       Impact factor: 4.164

9.  Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation.

Authors:  Hany S Abed; Chrishan S Samuel; Dennis H Lau; Darren J Kelly; Simon G Royce; Muayad Alasady; Rajiv Mahajan; Pawel Kuklik; Yuan Zhang; Anthony G Brooks; Adam J Nelson; Stephen G Worthley; Walter P Abhayaratna; Jonathan M Kalman; Gary A Wittert; Prashanthan Sanders
Journal:  Heart Rhythm       Date:  2012-09-01       Impact factor: 6.343

10.  Orchestrated regulation of energy supply and energy expenditure: Transcriptional coexpression of metabolism, ion homeostasis, and sarcomeric genes in mammalian myocardium.

Authors:  Andreas S Barth; Ami Kumordzie; Gordon F Tomaselli
Journal:  Heart Rhythm       Date:  2016-01-08       Impact factor: 6.343
View more
  3 in total

1.  Targeting amino acids metabolic profile to identify novel metabolic characteristics in atrial fibrillation.

Authors:  Jianqing She; Manyun Guo; Hongbing Li; Junhui Liu; Xiao Liang; Peining Liu; Bo Zhou; Simin Liu; Yangyang Deng; Bowen Lou; Chaofeng Sun; Zuyi Yuan; Yue Wu
Journal:  Clin Sci (Lond)       Date:  2018-10-05       Impact factor: 6.124

2.  HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice.

Authors:  Beatrix Scholz; Jan Sebastian Schulte; Sabine Hamer; Kirsten Himmler; Florentina Pluteanu; Matthias Dodo Seidl; Juliane Stein; Eva Wardelmann; Elke Hammer; Uwe Völker; Frank Ulrich Müller
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-03

3.  Comprehensive metabolomic characterization of atrial fibrillation.

Authors:  Chengcan Lu; Chunyan Liu; Di Mei; Mengjie Yu; Jian Bai; Xue Bao; Min Wang; Kejia Fu; Xin Yi; Weihong Ge; Jizhong Shen; Yuzhu Peng; Wei Xu
Journal:  Front Cardiovasc Med       Date:  2022-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.